www.prnewswire.com
Open in
urlscan Pro
2606:4700::6812:15bb
Public Scan
URL:
https://www.prnewswire.com/news-releases/accelerating-the-development-of-new-molecules---promethium-to-empower-ml-models-fo...
Submission: On August 01 via manual from IN — Scanned from DE
Submission: On August 01 via manual from IN — Scanned from DE
Form analysis 1 forms found in the DOM
<form class="search-bar">
<div class="input-group">
<input type="hidden" id="sitesearchurl" name="searchlink" value="/search/all/">
<input type="hidden" id="prodsearchurl" name="prodsearchlink" value="/search/products/">
<input type="hidden" id="resourcesearchurl" name="resourcesearchlink" value="/search/resources/">
<input type="hidden" id="orgsearchurl" name="orgsearchlink" value="/search/organization/">
<input type="hidden" id="allnewssearchurl" name="allnewssearchlink" value="/search/news/">
<input type="hidden" id="enableQuickSearch" name="enableQuickSearch" value="true">
<input type="hidden" id="newsVanityPathURL" name="newsVanityPathURL" value="/news/">
<input type="hidden" id="currentPagePathURL" name="currentPagePathURL" value="/content/prnewswire/us/en/news-releases">
<label class="search-label" id="Search" for="sitesearchbox">Search</label>
<span class="sr-only" id="autopoplabel">When typing in this field, a list of search results will appear and be automatically updated as you type.</span>
<input type="text" id="sitesearchbox" name="Search" aria-controls="results" aria-haspopup="listbox" aria-expanded="false" aria-describedby="autopoplabel" autocomplete="off" aria-autocomplete="list" class="form-control form-search"
placeholder="Search News Releases, Organizations, Resources, and Products">
</div>
<div class="qs-error">
</div>
</form>Text Content
Close menu
NewsProductsContact
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* 3 News in Focus
* 5 Business & Money
* 5 Science & Tech
* 5 Lifestyle & Health
* 0 Policy & Public Interest
* 1 People & Culture
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* Overview
* Distribution by PR Newswire
* Cision IR
* SocialBoost
* All Products
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
* General Inquiries
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
* Send a Release
* Sign Up
* Log In
* Resources
* Blog
* Journalists
* RSS
* GDPR
*
Close submenu (News in Focus)News in Focus
* Browse All News
* Multimedia Gallery
* Trending Topics
Close submenu (Business & Money)Business & Money
* Auto & Transportation
* Business Technology
* Entertainment & Media
* Financial Services & Investing
* General Business
Close submenu (Science & Tech)Science & Tech
* Consumer Technology
* Energy & Natural Resources
* Environment
* Heavy Industry & Manufacturing
* Telecommunications
Close submenu (Lifestyle & Health)Lifestyle & Health
* Consumer Products & Retail
* Entertainment & Media
* Health
* Sports
* Travel
Close submenu (Policy & Public Interest)Policy & Public Interest
Close submenu (People & Culture)People & Culture
* People & Culture
* Resources
* Blog
* Journalists
* Log In
* Sign Up
* Data Privacy
* Send a Release
* News
* Products
* Contact
Search
Search When typing in this field, a list of search results will appear and be
automatically updated as you type.
Searching for your content...
No results found. Please change your search terms and try again.
* News in Focus
* * BROWSE NEWS RELEASES
* All News Releases
* All Public Company
* English-only
* NEWS RELEASES OVERVIEW
* MULTIMEDIA GALLERY
* All Multimedia
* All Photos
* All Videos
* MULTIMEDIA GALLERY OVERVIEW
* TRENDING TOPICS
* All Trending Topics
* Business & Money
* * AUTO & TRANSPORTATION
* All Automotive & Transportation
* Aerospace, Defense
* Air Freight
* Airlines & Aviation
* Automotive
* Maritime & Shipbuilding
* Railroads and Intermodal Transportation
* Supply Chain/Logistics
* Transportation, Trucking & Railroad
* Travel
* Trucking and Road Transportation
* AUTO & TRANSPORTATION OVERVIEW
* VIEW ALL AUTO & TRANSPORTATION
* BUSINESS TECHNOLOGY
* All Business Technology
* Blockchain
* Broadcast Tech
* Computer & Electronics
* Computer Hardware
* Computer Software
* Data Analytics
* Electronic Commerce
* Electronic Components
* Electronic Design Automation
* Financial Technology
* High Tech Security
* Internet Technology
* Nanotechnology
* Networks
* Peripherals
* Semiconductors
* BUSINESS TECHNOLOGY OVERVIEW
* VIEW ALL BUSINESS TECHNOLOGY
* ENTERTAINMENT & MEDIA
* All Entertainment & Media
* Advertising
* Art
* Books
* Entertainment
* Film and Motion Picture
* Magazines
* Music
* Publishing & Information Services
* Radio & Podcast
* Television
* ENTERTAINMENT & MEDIA OVERVIEW
* VIEW ALL ENTERTAINMENT & MEDIA
* FINANCIAL SERVICES & INVESTING
* All Financial Services & Investing
* Accounting News & Issues
* Acquisitions, Mergers and Takeovers
* Banking & Financial Services
* Bankruptcy
* Bond & Stock Ratings
* Conference Call Announcements
* Contracts
* Cryptocurrency
* Dividends
* Earnings
* Earnings Forecasts & Projections
* Financing Agreements
* Insurance
* Investments Opinions
* Joint Ventures
* Mutual Funds
* Private Placement
* Real Estate
* Restructuring & Recapitalization
* Sales Reports
* Shareholder Activism
* Shareholder Meetings
* Stock Offering
* Stock Split
* Venture Capital
* FINANCIAL SERVICES & INVESTING OVERVIEW
* VIEW ALL FINANCIAL SERVICES & INVESTING
* GENERAL BUSINESS
* All General Business
* Awards
* Commercial Real Estate
* Corporate Expansion
* Earnings
* Environmental, Social and Governance (ESG)
* Human Resource & Workforce Management
* Licensing
* New Products & Services
* Obituaries
* Outsourcing Businesses
* Overseas Real Estate (non-US)
* Personnel Announcements
* Real Estate Transactions
* Residential Real Estate
* Small Business Services
* Socially Responsible Investing
* Surveys, Polls and Research
* Trade Show News
* GENERAL BUSINESS OVERVIEW
* VIEW ALL GENERAL BUSINESS
* Science & Tech
* * CONSUMER TECHNOLOGY
* All Consumer Technology
* Artificial Intelligence
* Blockchain
* Cloud Computing/Internet of Things
* Computer Electronics
* Computer Hardware
* Computer Software
* Consumer Electronics
* Cryptocurrency
* Data Analytics
* Electronic Commerce
* Electronic Gaming
* Financial Technology
* Mobile Entertainment
* Multimedia & Internet
* Peripherals
* Social Media
* STEM (Science, Tech, Engineering, Math)
* Supply Chain/Logistics
* Wireless Communications
* CONSUMER TECHNOLOGY OVERVIEW
* VIEW ALL CONSUMER TECHNOLOGY
* ENERGY & NATURAL RESOURCES
* All Energy
* Alternative Energies
* Chemical
* Electrical Utilities
* Gas
* General Manufacturing
* Mining
* Mining & Metals
* Oil & Energy
* Oil and Gas Discoveries
* Utilities
* Water Utilities
* ENERGY & NATURAL RESOURCES OVERVIEW
* VIEW ALL ENERGY & NATURAL RESOURCES
* ENVIRONMENT
* All Environment
* Conservation & Recycling
* Environmental Issues
* Environmental Policy
* Environmental Products & Services
* Green Technology
* Natural Disasters
* ENVIRONMENT OVERVIEW
* VIEW ALL ENVIRONMENT
* HEAVY INDUSTRY & MANUFACTURING
* All Heavy Industry & Manufacturing
* Aerospace & Defense
* Agriculture
* Chemical
* Construction & Building
* General Manufacturing
* HVAC (Heating, Ventilation and Air-Conditioning)
* Machinery
* Machine Tools, Metalworking and Metallurgy
* Mining
* Mining & Metals
* Paper, Forest Products & Containers
* Precious Metals
* Textiles
* Tobacco
* HEAVY INDUSTRY & MANUFACTURING OVERVIEW
* VIEW ALL HEAVY INDUSTRY & MANUFACTURING
* TELECOMMUNICATIONS
* All Telecommunications
* Carriers and Services
* Mobile Entertainment
* Networks
* Peripherals
* Telecommunications Equipment
* Telecommunications Industry
* VoIP (Voice over Internet Protocol)
* Wireless Communications
* TELECOMMUNICATIONS OVERVIEW
* VIEW ALL TELECOMMUNICATIONS
* Lifestyle & Health
* * CONSUMER PRODUCTS & RETAIL
* All Consumer Products & Retail
* Animals & Pets
* Beers, Wines and Spirits
* Beverages
* Bridal Services
* Cannabis
* Cosmetics and Personal Care
* Fashion
* Food & Beverages
* Furniture and Furnishings
* Home Improvement
* Household, Consumer & Cosmetics
* Household Products
* Jewelry
* Non-Alcoholic Beverages
* Office Products
* Organic Food
* Product Recalls
* Restaurants
* Retail
* Supermarkets
* Toys
* CONSUMER PRODUCTS & RETAIL OVERVIEW
* VIEW ALL CONSUMER PRODUCTS & RETAIL
* ENTERTAINMENT & MEDIA
* All Entertainment & Media
* Advertising
* Art
* Books
* Entertainment
* Film and Motion Picture
* Magazines
* Music
* Publishing & Information Services
* Radio & Podcast
* Television
* ENTERTAINMENT & MEDIA OVERVIEW
* VIEW ALL ENTERTAINMENT & MEDIA
* HEALTH
* All Health
* Biometrics
* Biotechnology
* Clinical Trials & Medical Discoveries
* Dentistry
* FDA Approval
* Fitness/Wellness
* Health Care & Hospitals
* Health Insurance
* Infection Control
* International Medical Approval
* Medical Equipment
* Medical Pharmaceuticals
* Mental Health
* Pharmaceuticals
* Supplementary Medicine
* HEALTH OVERVIEW
* VIEW ALL HEALTH
* SPORTS
* All Sports
* General Sports
* Outdoors, Camping & Hiking
* Sporting Events
* Sports Equipment & Accessories
* SPORTS OVERVIEW
* VIEW ALL SPORTS
* TRAVEL
* All Travel
* Amusement Parks and Tourist Attractions
* Gambling & Casinos
* Hotels and Resorts
* Leisure & Tourism
* Outdoors, Camping & Hiking
* Passenger Aviation
* Travel Industry
* TRAVEL OVERVIEW
* VIEW ALL TRAVEL
* Policy & Public Interest
* * POLICY & PUBLIC INTEREST
* All Policy & Public Interest
* Advocacy Group Opinion
* Animal Welfare
* Congressional & Presidential Campaigns
* Corporate Social Responsibility
* Domestic Policy
* Economic News, Trends, Analysis
* Education
* Environmental
* European Government
* FDA Approval
* Federal and State Legislation
* Federal Executive Branch & Agency
* Foreign Policy & International Affairs
* Homeland Security
* Labor & Union
* Legal Issues
* Natural Disasters
* Not For Profit
* Patent Law
* Public Safety
* Trade Policy
* U.S. State Policy
* POLICY & PUBLIC INTEREST OVERVIEW
* VIEW ALL POLICY & PUBLIC INTEREST
* People & Culture
* * PEOPLE & CULTURE
* All People & Culture
* Aboriginal, First Nations & Native American
* African American
* Asian American
* Children
* Diversity, Equity & Inclusion
* Hispanic
* Lesbian, Gay & Bisexual
* Men's Interest
* People with Disabilities
* Religion
* Senior Citizens
* Veterans
* Women
* PEOPLE & CULTURE OVERVIEW
* VIEW ALL PEOPLE & CULTURE
* In-Language News
* Arabic
* español
* português
* Česko
* Danmark
* Deutschland
* España
* France
* Italia
* Nederland
* Norge
* Polska
* Portugal
* Россия
* Slovensko
* Suomi
* Sverige
* Overview
* Distribution by PR Newswire
* Cision IR
* Guaranteed Paid Placement
* SocialBoost
* All Products
* General Inquiries
* Editorial Bureaus
* Partnerships
* Media Inquiries
* Worldwide Offices
*
*
* Send a Release
*
* * ALL CONTACT INFO
* Contact Us
888-776-0942
from 8 AM - 10 PM ET
*
* *
ACCELERATING THE DEVELOPMENT OF NEW MOLECULES - PROMETHIUM TO EMPOWER ML MODELS
FOR DRUG DISCOVERY USING NVIDIA QUANTUM CLOUD
--------------------------------------------------------------------------------
News provided by
QC Ware Corp.
Mar 18, 2024, 18:00 ET
SHARE THIS ARTICLE
Share toX
Share this article
Share toX
--------------------------------------------------------------------------------
PALO ALTO, Calif., March 18, 2024 /PRNewswire/ -- QC Ware, makers of Promethium,
a quantum-inspired, molecular discovery platform, announced today it is
leveraging NVIDIA Quantum Cloud to accelerate drug discovery by providing AI
platforms with the ability to generate highly accurate training data on large,
complex molecules faster than ever before, aiming to redefine the landscape of
in silico molecular simulation. These are critical problems that will be
accelerated by future quantum computers, but today are best solved by advanced
methods on GPUs. This will enable molecular AI platforms to train better ML
models, ultimately helping pharmaceutical companies find quality drug candidates
more quickly.
Continue Reading
NVIDIA Quantum Cloud is a microservice that lets users for the first time build
and test in the cloud new quantum algorithms and applications, including
powerful simulators and tools for hybrid quantum-classical programming.
Promethium to Empower ML Models for Drug Discovery Using NVIDIA Quantum Cloud
Post this
"Promethium is helping steer the future of drug discovery and this latest work
with NVIDIA signifies our commitment to advancing pharmaceutical research and
underscores the importance of technological innovation in the quest for
groundbreaking solutions to some of the most challenging medicinal problems of
modern times," said Paul Baines, VP of Product & Engineering, at QC Ware.
ML models are already playing a large role in drug discovery, accelerating the
ability to find new and promising candidates for clinical trials over historical
methods. With an abundance of these ML models coming into play, one of the main
challenges that research leaders face is determining the quality of the models
they are using. Typically, the best ML models are trained on the best data. This
has created a need for large amounts of extremely high-quality data.
The molecular data that currently exists is limited in scale, scope, and
application. To build the best general-purpose ML model, or to customize an ML
model for a specific purpose, lots of data must be generated — and fast.
Promethium is on a journey to generate the highest-quality data faster than it's
ever been done. AI platforms for drug discovery are already taking advantage of
these benefits. One example is a venture-backed start-up using Promethium to
create highly accurate data, very quickly, and at scale.
"For representative systems we currently run today, Promethium is 30 times
faster than our current toolsets," says the startup's CTO. "This means that we
can generate high-quality training data faster, leading to extremely accurate ML
models for researchers to use. The result? Truly transformative ML models that
will unlock massive amounts of value for pharmaceutical companies."
Additionally, this type of data has yet to be created at scale for larger
molecules. This was primarily due to how computationally intensive it was to
create accurate data for molecular modeling. This limitation kept ML models from
accurately predicting properties of larger molecules. Promethium's breakthrough
software, combined with NVIDIA's state-of-the-art GPUs and cloud scalability,
has unlocked the ability to create training data for large, complex molecules
that will fuel the advanced capabilities of innovative AI platforms.
"Quantum computing has the potential to transform drug discovery," said Tim
Costa, Director of HPC and Quantum at NVIDIA. "Promethium is using NVIDIA
Quantum Cloud to rapidly generate training data on large, complex molecules,
enabling better machine learning models that will help pharmaceutical companies
find drug candidates more quickly."
Leaders in the pharmaceutical industry are already taking advantage of AI as a
force multiplier in the drug discovery race. Not only is it helping them hone
in on more promising candidates more quickly, but it's also creating a new
benchmark for efficiency in R&D spend. Companies that are able to wield this
technology effectively will be poised to achieve or better maintain industry
dominance in the new age of drug discovery.
About QC Ware
Promethium is a quantum chemistry SaaS platform developed by QC Ware, a quantum
and classical computing software and services company focused on delivering
enterprise value through cutting-edge computational technology. With
specialization in machine learning and chemistry simulation applications, QC
Ware develops software for both near-term quantum and state-of-the-art classical
computing hardware. QC Ware's team is composed of some of the industry's
foremost experts in quantum and classical computing. QC Ware is headquartered in
Palo Alto, California, and supports its European customers through its
subsidiary in Paris and customers in Asia through its business development
office in Tokyo, Japan.
Media Contact:
Joseph.stamper@qcware.com
317-525-5882
SOURCE QC Ware Corp.
×
MODAL TITLE
ALSO FROM THIS SOURCE
QC WARE ANNOUNCES 3RD Q2B TOKYO CONFERENCE, FOCUSING ON THE ROADMAP TO QUANTUM
VALUE IN ASIA AND BEYOND
QC Ware, a leading provider of industry-disrupting quantum and quantum-inspired
machine learning and chemistry simulation solutions, today announced...
QC WARE ANNOUNCES 2ND Q2B PARIS CONFERENCE, FOCUSING ON THE ROADMAP TO QUANTUM
VALUE IN EUROPE
QC Ware, a leading provider of industry-disrupting quantum and quantum-inspired
machine learning, and chemistry simulation solutions, today announced ...
More Releases From This Source
EXPLORE
Computer & Electronics
Computer Software
Computer Software
Medical Pharmaceuticals
News Releases in Similar Topics
CONTACT PR NEWSWIRE
* Call 888-776-0942
from 8 AM - 9 PM ET
* Chat with an Expert
Contact Us
* General Inquiries
* Partnerships
* Media Inquiries
PRODUCTS
* For Marketers
* For Public Relations
* For IR & Compliance
* For Agency
* For Small Business
* All Products
ABOUT
* About PR Newswire
* About Cision
* Become a Publishing Partner
* Become a Channel Partner
* Careers
* Accessibility Statement
Global Sites
* Asia
* APAC
* APAC - Traditional Chinese
* Brazil
* Canada
* Czech
* Denmark
* Finland
* France
* Germany
* India
* Indonesia
* Israel
* Korea
* Italy
* Japan
* Mexico
* Middle East
* Middle East - Arabic
* Netherlands
* Norway
* Poland
* Portugal
* Russia
* Slovakia
* Spain
* Sweden
* United Kingdom
MY SERVICES
* All New Releases
* Online Member Center
* ProfNet
CONTACT PR NEWSWIRE
PRODUCTS
ABOUT
My Services
* All News Releases
* Online Member Center
* ProfNet
PR Newswire Distribution Helpline
888-776-0942
* Terms of Use
* Privacy Policy
* Information Security Policy
* Site Map
* RSS
* Cookie Settings
Copyright © 2024 Cision US Inc.
WE VALUE YOUR PRIVACY
We use cookies to personalize content and ads, to provide social media features
and to analyse our traffic. We also share information about your use of our site
with our social media, advertising and analytics partners. Cookie Policy.
Accept All Cookies
Manage Preferences
PRIVACY PREFERENCE CENTER
When you visit any website, it may store or retrieve information on your
browser, mostly in the form of cookies. This information might be about you,
your preferences or your device and is mostly used to make the site work as you
expect it to. The information does not usually directly identify you, but it can
give you a more personalized web experience. Because we respect your right to
privacy, you can choose not to allow some types of cookies. Click on the
different category headings to find out more and change our default settings.
However, blocking some types of cookies may impact your experience of the site
and the services we are able to offer.
cookies page
Accept All
MANAGE CONSENT PREFERENCES
STRICTLY NECESSARY
Always Active
These technologies are needed to enable our websiteto run and keep it secure.
PERFORMANCE ANALYTICS
Performance Analytics
These technologies tell us how you use our sites and apps, and provide
information to help us improve the website and browser experience.
FUNCTIONAL
Functional
These technologies allow us to provide enhanced functionality and personalise
content for you. For example they're used to recognise you when you return to
our website. If you do not allow these technologies then some or all these
services may not function properly.
MARKETING
Marketing
These services helps us decide which products, services and content may be
relevant for you. We use this data to customise the content you see on our
websites and social media. These technologies are set by us or by our
carefully-selected third parties. They help us understand the performance of our
marketing activities and improve the relevance of the content that you see.
Back Button
COOKIE LIST
Search Icon
Filter Icon
Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label
Confirm My Choices